Suppr超能文献

草药复方“芎由饮”通过抑制肝癌干细胞特性增加肝癌细胞对奥沙利铂的敏感性。

Herbal Compound "Songyou Yin" Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness.

机构信息

Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, 180 Fenglin Road, Shanghai 200032, China.

出版信息

Evid Based Complement Alternat Med. 2012;2012:908601. doi: 10.1155/2012/908601. Epub 2012 Dec 20.

Abstract

We investigated the effect of Chinese herbal compound Song-you Yin on HCC stemness. MHCC97H and Hep3B cell lines were pretreated with SYY for 4 weeks, and their chemosensitivity to oxaliplatin was evaluated. The expression of CSC-related markers, cell invasion and migration, and colony formation were also examined. SYY-treated orthotopic nude mouse models of human HCC were developed to explore the effect of oxaliplatin on tumor growth, metastasis, and survival. The CSC-related molecular changes in vivo were also evaluated. The result showed that MHCC97H and Hep3B cells pretreated with SYY showed significantly increased chemosensitivity to oxaliplatin and the downregulation of CSC-related markers CD90, CD24, and EPCAM. SYY also attenuated cell motility, invasion, and colony formation in MHCC97H and Hep3B cell lines. The reduced tumorigenicity and pulmonary metastasis were observed in SYY-pretreated cell lines. Combination treatment with oxaliplatin and SYY significantly reduced tumor volume and pulmonary metastasis and prolonged survival compared with oxaliplatin treatment alone. Immunohistochemical analysis showed reduced expression of CD90, ABCG2, ALDH, CD44, EPCAM, vimentin, and MMP-9 and increased the expression of E-cadherin, in HCC cells following combination treatment. These data clearly demonstrate that SYY renders hepatocellular carcinoma sensitive to oxaliplatin through the inhibition of stemness.

摘要

我们研究了中药复方“松友饮”对肝癌干细胞特性的影响。MHCC97H 和 Hep3B 细胞系用 SYY 预处理 4 周,评估其对奥沙利铂的化疗敏感性。还检测了 CSC 相关标志物的表达、细胞侵袭和迁移以及集落形成。建立 SYY 处理的人 HCC 原位裸鼠模型,以探讨奥沙利铂对肿瘤生长、转移和生存的影响。还评估了体内 CSC 相关的分子变化。结果表明,用 SYY 预处理的 MHCC97H 和 Hep3B 细胞对奥沙利铂的化疗敏感性显著增加,且 CSC 相关标志物 CD90、CD24 和 EPCAM 的表达下调。SYY 还减弱了 MHCC97H 和 Hep3B 细胞系中的细胞迁移、侵袭和集落形成。在 SYY 预处理的细胞系中观察到肿瘤生成和肺转移减少。与单独奥沙利铂治疗相比,奥沙利铂和 SYY 的联合治疗显著降低了肿瘤体积和肺转移,并延长了生存时间。免疫组织化学分析显示,联合治疗后 HCC 细胞中 CD90、ABCG2、ALDH、CD44、EPCAM、波形蛋白和 MMP-9 的表达减少,E-钙黏蛋白的表达增加。这些数据清楚地表明,SYY 通过抑制干细胞特性使肝癌对奥沙利铂敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f7/3541605/80f0bdeb38d5/ECAM2012-908601.001.jpg

相似文献

引用本文的文献

本文引用的文献

1
Methods for cancer stem cell detection and isolation.癌症干细胞检测与分离方法。
Methods Mol Biol. 2012;879:513-29. doi: 10.1007/978-1-61779-815-3_32.
2
Cancer stem cells: in the line of fire.肿瘤干细胞:成为攻击目标。
Cancer Treat Rev. 2012 Oct;38(6):589-98. doi: 10.1016/j.ctrv.2012.03.003. Epub 2012 Apr 1.
3
Hepatocellular carcinoma.肝细胞癌
N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683.
5
The power and the promise of liver cancer stem cell markers.肝癌干细胞标志物的威力与前景。
Stem Cells Dev. 2011 Dec;20(12):2023-30. doi: 10.1089/scd.2011.0012. Epub 2011 Aug 4.
6
Biology of hepatic cancer stem cells.肝癌干细胞的生物学特性。
J Gastroenterol Hepatol. 2011 Aug;26(8):1229-37. doi: 10.1111/j.1440-1746.2011.06762.x.
7
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验